Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer medicine"
DOI: 10.1002/cam4.6010
Abstract: Pheochromocytomas (PCCs) are rare neuroendocrine tumors derived from the chromaffin cells of the adrenal medulla. When these tumors have an extra-adrenal location, they are called paragangliomas (PGLs) and arise from sympathetic and parasympathetic ganglia, particularly… read more here.
Keywords: review; pccs pgls; diagnosis treatment; paragangliomas ... See more keywords
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.
Sign Up to like & getrecommendations! Published in 2017 at "Cancer cell"
DOI: 10.1016/j.ccell.2017.01.001
Abstract: We report a comprehensive molecular characterization of pheochromocytomas and paragangliomas (PCCs/PGLs), a rare tumor type. Multi-platform integration revealed that PCCs/PGLs are driven by diverse alterations affecting multiple genes and pathways. Pathogenic germline mutations occurred in… read more here.
Keywords: pccs pgls; molecular characterization; characterization pheochromocytoma; comprehensive molecular ... See more keywords
Cancer Stem Cells in Pheochromocytoma and Paraganglioma
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2020.00079
Abstract: Pheochromocytoma (PCC) and paraganglioma (PGL) are rare neuroendocrine tumors associated with high cardiovascular morbidity and variable risk of malignancy. The current therapy of choice is surgical resection. Nevertheless, PCCs/PGLs are associated with a lifelong risk… read more here.
Keywords: cancer stem; cells pheochromocytoma; pccs pgls; cancer ... See more keywords